Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles

Bone. 1997 Dec;21(6):501-6. doi: 10.1016/s8756-3282(97)00198-1.

Abstract

This study assessed the effect of low dose human parathyroid hormone [hPTH(1-34)] administration on cancellous and cortical bone of lumbar vertebrae in intact male beagles. 16 19-20-month-old beagle dogs were randomized into four groups: in group 1, the vehicle control group, saline was injected daily; in group 2, the sequential group, 0.375 microg/kg of PTH was injected daily for 4 weeks, then off 8 weeks, and this sequence was once repeated for another 4 and 8 weeks; in group 3, the same dose of PTH was injected once per week for 24 weeks; and, in group 4, PTH was injected three times per week for 24 weeks. Histomorphometric assessment on cancelllous and cortical bone (both ventral and dorsal shell) and two-dimensional node-strut analysis were done on the fifth lumbar vertebral bodies after calcein double bone labeling. In intact adult beagles, on the group treated with 0.375 microg/kg per day three times per week (group 4): (1) had a higher mean value in cancellous bone formation parameters [osteoid surface (+74%), osteoid volume (twofold), mineral apposition rate (+21%), and bone formation rate (twofold)]; (2) exhibited no effect on cortical thickness and porosity in both the ventral and dorsal shell; and (3) showed a lower mean value of node to termini (0.11 +/- 0.02 vs. 0.22 +/- 0.09) and a higher mean value of cortex to node (0.18 +/- 0.06 vs. 0.08 +/- 0.02), but not in trabeculae to trabeculae node, than age-related controls. In conclusion, we found that a low dose of PTH administration: (1) stimulated cancellous bone formation; (2) improved connectivity of trabeculae joined to the cortex; (3) did not decrease cortical thickness; and (4) did not increase cortical porosity in both ventral and dorsal cortexal shell of the lumbar vertebrae during this dosage and period in intact male beagles.

MeSH terms

  • Animals
  • Blood Proteins / drug effects
  • Blood Proteins / metabolism
  • Body Weight
  • Bone Density / drug effects
  • Bone and Bones / anatomy & histology
  • Bone and Bones / drug effects*
  • Calcium / blood
  • Dogs
  • Dose-Response Relationship, Drug
  • Humans
  • Lumbar Vertebrae / anatomy & histology
  • Lumbar Vertebrae / drug effects*
  • Male
  • Osteogenesis / drug effects
  • Parathyroid Hormone / administration & dosage*
  • Peptide Fragments / administration & dosage*
  • Phosphorus / blood
  • Porosity / drug effects
  • Teriparatide / administration & dosage*

Substances

  • Blood Proteins
  • Parathyroid Hormone
  • Peptide Fragments
  • Teriparatide
  • Phosphorus
  • Calcium